Cerus Corporation (CU2)
XDUS
Closed
Aug 24, 2026
Day's Range
2.3052 wk Range
0.9965Overview - CU2 - Cerus Corporation
Key Statistics
Valuation
Enterprise Value
76.98M
P/E (Trailing)
‪-28.74‬
PEG Ratio
‪0.43‬
Price / Book
‪6.52‬
EV / EBITDA
‪-18.16‬
Profitability
Gross Margin
‪51.41%‬
Profit Margin
‪54.47%‬
Operating Margin
‪-3.36%‬
Return on Assets
‪-7.04%‬
Return on Equity
‪-24.05%‬
Ownership
Shares Outstanding
201.45M
Price stats
50-Day Avg
‪2.44‬
200-Day Avg
‪1.99‬
Peers - CU2 - Cerus Corporation
Peer Comparison
Compared with companies in Medical Devices listed on XDUS.
- CU2XDUSCerus Corporation+55.09%52-week change-29.50P/E (Trailing)‪54.47%‬Profit Margin
- PENXDUSPBF Energy Inc.+66.09%52-week change-43.73P/E (Trailing)‪-1.94%‬Profit Margin
- 8HHXDUSAvanos Medical Inc.+53.94%52-week change-13.76P/E (Trailing)‪50.47%‬Profit Margin
- 6GJXDUSGlaukos Corporation+50.00%52-week change-48.17P/E (Trailing)‪55.72%‬Profit Margin
- 3L3XDUSTactile Systems Technology Inc.+45.05%52-week change24.12P/E (Trailing)‪75.91%‬Profit Margin
- 4ZGXDUSMedian Technologies S.A.+44.08%52-week change-4.86P/E (Trailing)‪102.97%‬Profit Margin
- VMEXDUSViromed Medical AG+43.55%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - CU2 - Cerus Corporation
About
Cerus Corporation is a biomedical products company dedicated to enhancing blood transfusion safety through its INTERCEPT Blood System. This platform inactivates a broad range of pathogens, including viruses, bacteria, and parasites, in blood components to reduce the risk of transfusion-transmitted infections. The…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
